What's going on with the Medibank share price today?

Shareholders will be happy to see Medibank shares drop in value today.

| More on:
private health insurance diagram.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 Index (ASX: XJO) seems to be gearing up for another tough day this Thursday. At the time of writing, the ASX 200 has slipped by 0.16% leaving the index at around 7,650 points. But let's talk about what's going on with the Medibank Private Ltd (ASX: MPL) share price.

On the surface, it looks as though Medibank shares are having an awful time today thus far. The private health insurance provider closed at $3.66 a share yesterday. But those same shares opened at $3.60 this morning, where they remain at present. That's a loss worth 1.64%.

Upon deeper inspection though, investors should be happy with this share price drop. That's because it is a consequence of Medibank shares trading ex-dividend today.

Last week, we covered Medibank's latest half-year earnings report, covering the six months to 31 December. As we discussed at the time, it was a fairly positive report card from Medibank Private.

The company announced that its revenue for the period rose by 3.3% up to $4.02 billion. Underlying profits rose by an even better 16.3% to $262.5 million, which enabled Medibank to unveil an interim dividend of 7.2 cents per share, fully franked, for the half-year.

This was a big announcement for the company. Firstly, this new dividend of 7.3 cents per share was a 14.3% rise over last year's interim dividend of 6.3 cents per share.

But this new payout is also set to be the largest interim dividend Medibank has ever paid out in its history as a public company. It takes Medibank's full-year payouts from 14.6 cents per share to 15.5 cents. That's including the final dividend of 8.3 cents per share that we saw last October.

Why are Medibank shares dropping this Thursday?

As we warned on Tuesday, yesterday was the last day you could have bought Medibank shares with the rights to receive this dividend attached.

Today, the company has just traded ex-dividend.

When a company trades ex-dividend, it cuts off new investors from eligibility for an upcoming shareholder payment. This means that Medibank shares have just become slightly less valuable, given new investors from today will have to wait until Medibank's second dividend of 2024 to start receiving income from the company.

So the resulting fall in share price that we are witnessing today is completely normal.

For eligible investors, Medibank's latest dividend is scheduled to arrive in bank accounts next month on 20 March.

At the current Medibank Private share price, this ASX 200 health insurer is trading on a dividend yield of 4.31%.

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A women has her eyes checked at the optometrist.
Healthcare Shares

Is Medibank stock a good buy?

Can this company provide healthy returns?

Read more »

A woman jumps for joy with a rocket drawn on the wall behind her.
Healthcare Shares

Guess which ASX healthcare stock is jumping 7% on US FDA approval news

This share is giving its shareholders an early Christmas present.

Read more »

A senior pharmacist talks to a customer at the counter in a shop
Healthcare Shares

Is it too late to buy Sigma shares to cash in on the Chemist Warehouse deal?

Can investors still make healthy returns with this stock?

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

Why the Mesoblast share price is diving 18% after an FDA win

Investors are sending the Mesoblast share price tumbling on Friday. But why?

Read more »

A happy doctor in a white coat dancing due to his excitement over the EBOS acquisition
Healthcare Shares

Mesoblast share price rockets 30% on big US FDA news

Big news is giving this biotech a huge lift on Thursday.

Read more »

Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.
Healthcare Shares

Guess which ASX healthcare stock is jumping 12% on Wednesday

This shares is rocketing this morning. But why? Let's find out.

Read more »

Man holding out Australian dollar notes, symbolising dividends.
Healthcare Shares

Here is the dividend forecast to 2029 for CSL shares

Can this blue-chip giant provide healthy dividend income?

Read more »

a doctor in a white coat makes a heart shape with his hands and holds it over his chest where his heart is placed.
Healthcare Shares

The best ASX 200 healthcare stocks to buy in 2025

These shares could give your portfolio a healthy boost next year according to Bell Potter.

Read more »